
A professional journalist, Paolo has been involved in scientific popularisation for many years, especially in the field of medicine and biology. He is the creator of Sportello Cancro, the site created by corriere.it on oncology in collaboration with the Umberto Veronesi Foundation. He has written for the Science pages of Corriere della Sera and other national newspapers. He is founder and director of PRC-Comunicare la scienza.
Blog Post by Paolo Rossi Castelli
Paolo Rossi Castelli22 Dec 20217 min read
The Alliance for a sustainable future involves Art, Music and Architecture.
Primo Forum svizzero “Cultura e Salute – Alleanza per un futuro sostenibile”: due giornate di confronto sull’umanizzazione della cura e dei suoi spazi.
Start Reading
Paolo Rossi Castelli16 Dec 20212 min read
Two new strategies to fight Alzheimer’s disease
Two new trials to fight Alzheimer have produced successful results. These are a vaccine and a soluble form of beta amyloid protein typical of Alzheimer’s.
Start Reading
Paolo Rossi Castelli13 Dec 20212 min read
New molecules regenerate nerve fibres
Breakthrough results have been achieved in the USA. It is still early days for using on spinal injuries, but it seems to offer promising research potential
Start Reading
Paolo Rossi Castelli02 Dec 20212 min read
ALS, a new technique to block the wrong DNA
A therapy that can prevent DNA from copying genetic traits that may lead to hereditary forms of ALS has been successfully tested (so far only in the lab).
Start Reading
Paolo Rossi Castelli25 Nov 20213 min read
Is sleep really only good for the brain?
New studies reveal that even living beings with no nervous system need to sleep. Other parts of the body are affected like immune and digestive systems.
Start Reading
Paolo Rossi Castelli18 Nov 20212 min read
A 'liquid' vest to measure breath
Researchers have created a high-tech fabric that can detect slightest vibration. It will be useful for athletes, singers, and patients in rehabilitation.
Start Reading
Paolo Rossi Castelli11 Nov 20213 min read
‘Friendly’ viruses to defeat the most dangerous bacteria
A recent study has reproposed the idea of using ‘phages’- viruses that are harmless to humans but often lethal for bacteria – instead of antibiotics.
Start Reading
Paolo Rossi Castelli04 Nov 20214 min read
A vaccine ingredient (in short supply) from Chile
The bark of the Quillaja Saponaria tree contains saponins used as ‘adjuvants’ in the Covid vaccines by Novavax. However, excess demand may cause problems.
Start Reading
Paolo Rossi Castelli28 Oct 20213 min read
Will DNA mapping be the future for all newborns?
This UK pilot project involves 200,000 children. Its aim is early-stage diagnosis of rare genetic disease. There are some controversial issues to resolve.
Start Reading
Paolo Rossi Castelli21 Oct 20212 min read
In the wake of COVID, a Hepatitis C vaccine is on the horizon
An American team has discovered how the hepatitis virus enters the liver: it resembles the approach used by COVID-19. Now a vaccine is possible.
Start Reading
Paolo Rossi Castelli14 Oct 20212 min read
A surprising fact: fires ‘fertilise’ oceans
An international team studied the effects of Australia’s bushfires. Ash released into the air by burning trees becomes food for phytoplankton on the sea.
Start Reading
Paolo Rossi Castelli07 Oct 20214 min read
New DNA-based Covid vaccines
An Indian pharmaceutical company has been given the go-ahead to market a COVID DNA vaccine, which may pave the way for an entirely new category of vaccines
Start Reading
Paolo Rossi Castelli30 Sep 20213 min read
Arthrosis, cells from the nose to treat knees
A successful experiment at Basel hospital on two young patients with a serious form of arthrosis. Cells from the nasal septum were implanted in the knee.
Start Reading
Paolo Rossi Castelli23 Sep 20213 min read
Immunotherapy: testing to see if it works in advance
Some patients gain no benefit from cancer therapies, for reasons as yet unknown. US researchers have identified a marker to avoid unnecessary treatments.
Start Reading
Paolo Rossi Castelli09 Sep 20213 min read
Personalised oncological treatment with a special ‘sandwich’
A new device allows simulation of the effect of oncological treatment for various types of cancers and selection of the most effective for each patient.
Start Reading
Paolo Rossi Castelli02 Sep 20212 min read
Can intestinal bacteria help in the fight against tumours?
The substances produced by some types of microorganisms present in the intestine (microbiota) might improve the effect of oncological immunotherapy.
Start Reading
Paolo Rossi Castelli29 Jul 20213 min read
A means of ending Covid with defective copies of the virus?
When duplicated, viruses also create flawed copies of their genetic code. Once modified, these copies might actually be used as a treatment against Covid.
Start Reading
Paolo Rossi Castelli22 Jul 20213 min read
How an altered gene triggers Motor Neurone Disease (ALS)
A team of researchers has shed light on Amyotrophic Lateral Sclerosis, an illness which gradually paralyses muscles and currently has no effective cure.
Start Reading